Articles Published in 2011

Ewopharma acquires Immdal’s Newport Pharmaceuticals

Thursday, October 20, 2011 10:40 AM

Immdal, a privately held Irish pharmaceutical healthcare group, has sold its subsidiary Newport Pharmaceuticals to Swiss pharmaceutical company Ewopharma.

More... »

Proteostasis names Enyedy CEO

Thursday, October 20, 2011 10:27 AM

Proteostasis Therapeutics has named Mark J. Enyedy chief executive officer. Enyedy joins Proteostasis after serving 15 years at Genzyme, most recently as president of the transplant, oncology and multiple sclerosis divisions. Enyedy has also been elected to the Proteostasis board of directors.

More... »

Imagen Biotech secures $40 million in Series A financing

Thursday, October 20, 2011 10:22 AM

Imagen Biotech has secured up to $40 million in Series A financing from SV Life Sciences, Novo Ventures, and Fidelity Biosciences to pursue the identification and development of breakthrough treatments for blinding diseases with high unmet medical needs, including dry age-related macular degeneration. Matthew Feinsod, MD, an ophthalmologist who was formerly at Eyetech Pharmaceuticals and a medical officer in the FDA's Ophthalmology Division, will lead these efforts as chief medical officer for Imagen. Additional terms will not be disclosed.

More... »

Almac expands with new facility in UK

Thursday, October 20, 2011 10:11 AM

Almac has expands its pharmaceutical development services with the creation of a new facility at our UK headquarters in Craigavon.

More... »

Amgen names executive VP

Wednesday, October 19, 2011 01:50 PM

Amgen has named Anthony (Tony) Hooper, executive vice president, global commercial operations, effective October 26th. In this role, Hooper will report to Robert A. Bradway, president and chief operating officer.

More... »

Abbott to separate into two companies

Wednesday, October 19, 2011 01:14 PM

Abbott has announced plans to separate into two publicly traded companies, one in diversified medical products and the other in research-based pharmaceuticals.

More... »

Venture capital investments in life sciences fall in third quarter

Wednesday, October 19, 2011 01:07 PM

Venture capitalists invested $6.95 billion in 876 deals in the third quarter of 2011, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and the National Venture Capital Association (NVCA), based on data provided by Thomson Reuters.

More... »

Quintiles acquires VCG, strengthening commercial services

Wednesday, October 19, 2011 01:01 PM

Quintiles has acquired VCG & Associates and VCG BIO. The addition of VCG strengthens Quintiles’ comprehensive commercial services in sales and brand solutions, product solutions, product distribution and market access.

More... »

Quintiles acquires Outcome Sciences

Wednesday, October 19, 2011 12:52 PM

With late phase research becoming increasingly important to multiple healthcare stakeholders, Quintiles has acquired Outcome Sciences, a privately held outcomes research firm headquartered in Cambridge, Mass.

More... »

Genticel completes patient recruitment for ProCervix trial

Wednesday, October 19, 2011 11:31 AM

Genticel has completed the recruitment of all patients participating in its phase one clinical trial with a liquid formulation of ProCervix, its candidate therapeutic HPV vaccine designed for adult women already infected with human papillomavirus (HPV) genotype 16 or 18.

More... »